SCHEMBL17127027

SCHEMBL17127027

CCCCCSC(C(=O)c1ccc(Oc2ccc(OC)cc2)cc1)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 2/20 0.44
▸ HTT P42858 3/20 0.41
▸ SLC2A1 P11166 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HDAC3 O15379 2/20 0.40
▸ HDAC1 Q13547 2/20 0.40
▸ HDAC2 Q92769 2/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126974 0.96 PARP10 (0.46) PARP10HTTSLC2A1MEN1CYP2D6
SCHEMBL17127336 0.90 HDAC3 (0.46) PARP10HDAC3
SCHEMBL17127025 0.89 PARP10 (0.43) PARP10HTTSLC2A1ALDH1A1LMNA
SCHEMBL17127026 0.86 HDAC3 (0.47) PARP10SLC2A1ALDH1A1HDAC3
SCHEMBL17127363 0.86 PARP10 (0.46) PARP10HTTSLC2A1MEN1CYP2D6
SCHEMBL15935664 0.85 HTT (0.41) HTTSLC2A1MEN1CYP2D6KMT2A
SCHEMBL17126977 0.85 PARP10 (0.44) PARP10HTTSLC2A1ALDH1A1LMNA
SCHEMBL17127028 0.85 CETP (0.42) ALDH1A1LMNASMN1; SMN2HDAC3HDAC1
SCHEMBL17126973 0.84 SMN1; SMN2 (0.43) PARP10HTTSLC2A1MEN1CYP2D6
SCHEMBL17126978 0.81 CETP (0.40) SLC2A1MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS PARP10 611/4885HTT 1863/4885SLC2A1 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback